These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8623140)

  • 1. Anaphylaxis after treatment with recombinant factor VIII.
    Shopnick RI; Kazemi M; Brettler DB; Buckwalter C; Yang L; Bray G; Gomperts ED
    Transfusion; 1996 Apr; 36(4):358-61. PubMed ID: 8623140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactic reactions following infusion of factor VIII in a patient with classic hemophilia.
    Helmer RE; Alperin JB; Yunginger JW; Grant JA
    Am J Med; 1980 Dec; 69(6):953-7. PubMed ID: 6160766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.
    Bray GL; Gomperts ED; Courter S; Gruppo R; Gordon EM; Manco-Johnson M; Shapiro A; Scheibel E; White G; Lee M
    Blood; 1994 May; 83(9):2428-35. PubMed ID: 8167332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group.
    Lusher JM; Arkin S; Abildgaard CF; Schwartz RS
    N Engl J Med; 1993 Feb; 328(7):453-9. PubMed ID: 8421474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
    Bergamaschini L; Mannucci PM; Federici AB; Coppola R; Guzzoni S; Agostoni A
    J Lab Clin Med; 1995 Mar; 125(3):348-55. PubMed ID: 7897302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A.
    Hsu HC; Chen YF; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):450-4. PubMed ID: 10418180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization to factor VIII in a patient with classic hemophilia and C2 deficiency.
    Jamieson DM; Stafford CT; Maloney MJ; Lutcher CL
    Ann Allergy; 1987 Mar; 58(3):215-20. PubMed ID: 3103496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of clinical studies of recombinant factor VIII (recombinate) in patients with hemophilia A. Recombinate Study Group.
    Bray GL
    Transfus Med Rev; 1992 Oct; 6(4):252-5. PubMed ID: 1421824
    [No Abstract]   [Full Text] [Related]  

  • 10. Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity.
    Oldenburg J; Lacroix-Desmazes S; Lillicrap D
    Haematologica; 2015 Feb; 100(2):149-56. PubMed ID: 25638804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.
    Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J
    Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group.
    Schwartz RS; Abildgaard CF; Aledort LM; Arkin S; Bloom AL; Brackmann HH; Brettler DB; Fukui H; Hilgartner MW; Inwood MJ
    N Engl J Med; 1990 Dec; 323(26):1800-5. PubMed ID: 2123300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE-mediated anaphylactic reaction to purified and recombinant factor VIII in a patient with severe haemophilia A.
    Kadar JG; Schuster J; Hunzelmann N
    Haemophilia; 2007 Jan; 13(1):104-5. PubMed ID: 17212734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of immune tolerance in a 7-year-old hemophiliac with an anaphylactoid inhibitor.
    Harper JL; Gill JC; Hopp RJ; Evans J; Haire WD
    Thromb Haemost; 1995 Oct; 74(4):1039-41. PubMed ID: 8560409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to heterologous proteins in hemophilia A patients receiving recombinant factor VIII (Recombinate).
    Ingerslev J; Christiansen K; Ravn HB; Bray GL; Gomperts ED;
    Thromb Haemost; 2002 Apr; 87(4):626-34. PubMed ID: 12008945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis in patients with hemophilia.
    Jadhav M; Warrier I
    Semin Thromb Hemost; 2000; 26(2):205-8. PubMed ID: 10919414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.
    Gouw SC; van der Bom JG; Auerswald G; Ettinghausen CE; Tedgård U; van den Berg HM
    Blood; 2007 Jun; 109(11):4693-7. PubMed ID: 17218379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylaxis following the use of a plasma-derived immunopurified monoclate-P, and the recombinant Recombinate and Kogenate factor VIII: a therapeutic challenge.
    Pernod G; Armari C; Barro C; Plantaz D; Caperan D; Jacquot C; Polack B
    Haemophilia; 1999 Mar; 5(2):143-4. PubMed ID: 10215966
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of immune response to mouse IgG in hemophilia A patients treated chronically with Monoclate, a monoclonal antibody affinity purified factor VIII preparation.
    Davis HM; Brown SK; Nash DW; Pennetti AM; Salzman PM; Schreiber AB; Haimovich J
    Thromb Haemost; 1990 Jun; 63(3):386-91. PubMed ID: 2119524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.